![Michael B. Weiss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael B. Weiss
Corporate Officer/Principal at
Cahill Gordon & Reindel LLP
Profile
Michael B. Weiss is currently a Partner at Cahill Gordon & Reindel LLP since 1990.
He was previously a Director at Enumeral Biomedical Corp.
He received his graduate degree from the University of Virginia in 1990, his graduate degree from Emory University in 1986, and his undergraduate degree from Emory University in 1986.
Michael B. Weiss active positions
| Companies | Position | Start |
|---|---|---|
Cahill Gordon & Reindel LLP
 Cahill Gordon & Reindel LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/1990 |
Former positions of Michael B. Weiss
| Companies | Position | End |
|---|---|---|
Enumeral Biomedical Corp.
 Enumeral Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Develops monoclonal antibodies for diagnosis and treatment of infectious, autoimmune and inflammatory diseases | Director/Board Member | - |
Training of Michael B. Weiss
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
98
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cahill Gordon & Reindel LLP
Cahill Gordon & Reindel LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enumeral Biomedical Corp.
Enumeral Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Develops monoclonal antibodies for diagnosis and treatment of infectious, autoimmune and inflammatory diseases | Commercial Services |
- Stock Market
- Insiders
- Michael B. Weiss
